Open AccessSuccessful treatment of pulmonary nocardiosis with fluoroquinolone in bronchial asthma and bronchiectasis
Author(s) -
Sadamatsu Hironori,
Takahashi Koichiro,
Tashiro Hiroki,
Komiya Kazutoshi,
Nakamura Tomomi,
SueokaAragane Naoko
Publication year - 2017
Publication title -
respirology case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.304
H-Index - 9
ISSN - 2051-3380
DOI - 10.1002/rcr2.229
Subject(s) - bronchiectasis , medicine , sputum , chest radiograph , asthma , nocardia , gastroenterology , lung , surgery , pathology , tuberculosis , bacteria , biology , genetics
A 72‐year‐old Japanese woman was admitted at Saga University Hospital for fever, malaise, and productive cough. Six years ago, she had been diagnosed with bronchial asthma and was treated with inhaled corticosteroids. Chest radiograph and computed tomography on admission showed infiltrates in the right middle lobe, a mass lesion in the left lower lobe, and bronchiectasis in both lower lobes. Sputum examination showed Gram‐positive rods with phagocytosis by neutrophils. These bacilli were identified as Nocardia otitidiscaviarum by 16S ribosomal RNA sequencing. Therefore, she was diagnosed with pulmonary nocardiosis and was treated with trimethoprim/sulfamethoxazole ( TMP–SMX ) and minocycline ( MINO ). However, she had to discontinue these antibiotics because of severe nausea and anorexia and instead was treated with fluoroquinolone for 6 months. There was resolution of the disease thereafter. Pulmonary nocardiosis with bronchial asthma and bronchiectasis can be successfully treated with fluoroquinolone, an alternative to TMP–SMX or MINO .